Bacteria that make up the gut microbiome could be the cause for lack of therapeutic effect of orally administered drugs for diabetes in some people, according to the researchers at Wake Forest School of Medicine.
In a review of more than 100 current published studies in humans and rodents, the School of Medicine team examined how gut bacteria either enhanced or inhibited a drug's effectiveness. The review is published in the journal EBioMedicine.
Human Gut Microbiome Varies among Ethnicities
Changing the gut microbiome to fight illnesses does not hold great potential, reveals a finding. Whereas, gut microbiome differs among ethnicities, which is the consistent determining factor in illness.
Advertisement
‘Modifying the gut microbiome can improve the effectiveness of various drugs used for type-2 diabetes’
Read More..
Tweet it Now
Read More..
"For example, certain drugs work fine when given intravenously and go directly to the circulation, but when they are taken orally and pass through the gut, they don't work," said Hariom Yadav, Ph.D., assistant professor of molecular medicine at the School of Medicine, a part of Wake Forest Baptist Medical Center.
"Conversely, metformin, a commonly used anti-diabetes drug, works best when given orally but does not work when given through an IV."
The review examined interactions between the most commonly prescribed anti-diabetic drugs with the microbiome. Before being absorbed into the bloodstream, many orally-administered drugs are processed by intestinal microbial enzymes. As a result, the gut microbiome influences the metabolism of the drugs, thereby affecting patients' responses, Yadav said.
Type-2 diabetes, a disease characterized by carbohydrate and fat metabolism abnormalities, has recently become a global pandemic. One main function of gut microbiota is to metabolize non-digestive carbohydrates and regulate a person's metabolism.
"Our review showed that the metabolic capacity of a patient's microbiome could influence the absorption and function of these drugs by making them pharmacologically active, inactive or even toxic," he said. "We believe that differences in an individual's microbiome help explain why drugs will show a 90 or 50 percent optimum efficacy, but never 100 percent."
The researchers concluded that modulation of the gut microbiome by drugs may represent a target to improve, modify or reverse the effectiveness of current medications for type-2 diabetes.
"This field is only a decade old, and the possibility of developing treatments derived from bacteria related to or involved in specific diseases is tantalizing," Yadav said.
Source: Eurekalert
The review examined interactions between the most commonly prescribed anti-diabetic drugs with the microbiome. Before being absorbed into the bloodstream, many orally-administered drugs are processed by intestinal microbial enzymes. As a result, the gut microbiome influences the metabolism of the drugs, thereby affecting patients' responses, Yadav said.
Advertisement
Type-2 diabetes, a disease characterized by carbohydrate and fat metabolism abnormalities, has recently become a global pandemic. One main function of gut microbiota is to metabolize non-digestive carbohydrates and regulate a person's metabolism.
"Our review showed that the metabolic capacity of a patient's microbiome could influence the absorption and function of these drugs by making them pharmacologically active, inactive or even toxic," he said. "We believe that differences in an individual's microbiome help explain why drugs will show a 90 or 50 percent optimum efficacy, but never 100 percent."
The researchers concluded that modulation of the gut microbiome by drugs may represent a target to improve, modify or reverse the effectiveness of current medications for type-2 diabetes.
"This field is only a decade old, and the possibility of developing treatments derived from bacteria related to or involved in specific diseases is tantalizing," Yadav said.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
Researchers have shown that gestational diabetes can be identified as early as the first trimester of pregnancy, which is typically months before it is typically diagnosed.
A new smartphone app or support tool developed helps improve mental health in individuals with type 1 diabetes.
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.